← SynDRA
UNC-2250
SynDRA canonical compound SYN0079800 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MERTK |
| Mechanism of action | MER tyrosine kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- MER tyrosine kinase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- L3MBTL1
- L3MBTL3
- AOX1
- CBX7
- HDAC6
- KDM5A
- L3MBTL4
- MBTD1
- PHF13
- PHF23
- SFMBT1
- TP53BP1
- UHRF1
Cross-references
Synonyms
- AS-55930
- HY-15797
- US9649309, Compound UNC2250B
- ZINC253387880
- UNC2250
- CCG-269128
- SB52242
- ZINC96170458
- BRD-K01773560-001-01-6
- UNC 2250
- MFCD27992060
- 4-[[2-(Butylamino)-5-[5-(morpholin-4-ylmethyl)pyridin-2-yl]pyrimidin-4-yl]amino]cyclohexan-1-ol
- BDBM308180
- UNC2250?
- orb1306933
- FD5023
- AKOS027338220
- AKOS026750288
- BRD-K01773560-001-02-4
- C24H36N6O2
- HMS3740M13
- NCGC00386394-03
- AC-31423
- SCHEMBL29392311
- SCHEMBL16435535
- DA-44178
- A14143
- trans-4-[[2-(Butylamino)-5-[5-(morpholinomethyl)-2-pyridyl]-4-pyrimidinyl]amino]cyclohexanol
- BDBM50444042
- (1r,4r)-4-(2-(butylamino)-5-(5-(morpholinomethyl)pyridin-2-yl)pyrimidin-4-ylamino)cyclohexanol
- SCHEMBL16438463
- EX-A2175
- s7342
- CHEMBL3092807
- ZINC102240028
- UNC-5520
- (1R,4r)-4-((2-(butylamino)-5-(5-(morpholinomethyl)pyridin-2-yl)pyrimidin-4-yl)amino)cyclohexanol
- NCGC00386394-04
- (1r,4r)-4-{[2-(butylamino)-5-[5-(morpholin-4-ylmethyl)pyridin-2-yl]pyrimidin-4-yl]amino}cyclohexan-1-ol
Look up UNC-2250 in the interactive SynDRA portal →